Structure

Physi-Chem Properties

Molecular Weight:  760.29
Volume:  778.853
LogP:  8.393
LogD:  3.514
LogS:  -2.045
# Rotatable Bonds:  8
TPSA:  194.21
# H-Bond Aceptor:  11
# H-Bond Donor:  7
# Rings:  7
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.067
Synthetic Accessibility Score:  5.304
Fsp3:  0.289
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  2
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.841
MDCK Permeability:  7.025215836620191e-06
Pgp-inhibitor:  0.699
Pgp-substrate:  0.185
Human Intestinal Absorption (HIA):  0.149
20% Bioavailability (F20%):  0.891
30% Bioavailability (F30%):  0.981

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.0
Plasma Protein Binding (PPB):  98.09073638916016%
Volume Distribution (VD):  0.489
Pgp-substrate:  5.634170055389404%

ADMET: Metabolism

CYP1A2-inhibitor:  0.088
CYP1A2-substrate:  0.319
CYP2C19-inhibitor:  0.943
CYP2C19-substrate:  0.054
CYP2C9-inhibitor:  0.904
CYP2C9-substrate:  0.969
CYP2D6-inhibitor:  0.729
CYP2D6-substrate:  0.254
CYP3A4-inhibitor:  0.289
CYP3A4-substrate:  0.227

ADMET: Excretion

Clearance (CL):  11.774
Half-life (T1/2):  0.036

ADMET: Toxicity

hERG Blockers:  0.027
Human Hepatotoxicity (H-HT):  0.968
Drug-inuced Liver Injury (DILI):  0.956
AMES Toxicity:  0.056
Rat Oral Acute Toxicity:  0.831
Maximum Recommended Daily Dose:  0.959
Skin Sensitization:  0.942
Carcinogencity:  0.046
Eye Corrosion:  0.003
Eye Irritation:  0.863
Respiratory Toxicity:  0.065

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC477529

Natural Product ID:  NPC477529
Common Name*:   (5aS,10aR)-2-[(1R,5S,6R)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-1,3,8-trihydroxy-5a-(3-methylbut-2-enyl)-10aH-[1]benzofuro[3,2-b]chromen-11-one
IUPAC Name:   (5aS,10aR)-2-[(1R,5S,6R)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-1,3,8-trihydroxy-5a-(3-methylbut-2-enyl)-10aH-[1]benzofuro[3,2-b]chromen-11-one
Synonyms:  
Standard InCHIKey:  GCSSGYKMPPFQLH-KDJZGPCZSA-N
Standard InCHI:  InChI=1S/C45H44O11/c1-21(2)6-9-27-32(48)13-11-28(40(27)51)41(52)37-29(26-10-7-24(46)18-33(26)49)16-23(5)17-30(37)38-34(50)20-36-39(42(38)53)43(54)44-45(56-36,15-14-22(3)4)31-12-8-25(47)19-35(31)55-44/h6-8,10-14,17-20,29-30,37,44,46-51,53H,9,15-16H2,1-5H3/t29-,30-,37-,44+,45+/m1/s1
SMILES:  CC1=C[C@H]([C@@H]([C@H](C1)C2=C(C=C(C=C2)O)O)C(=O)C3=C(C(=C(C=C3)O)CC=C(C)C)O)C4=C(C5=C(C=C4O)O[C@@]6([C@H](C5=O)OC7=C6C=CC(=C7)O)CC=C(C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   90681447
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002650] Diarylheptanoids
        • [CHEMONTID:0002651] Linear diarylheptanoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19738 Morus nigra Species Moraceae Eukaryota n.a. bark n.a. PMID[18330242]
NPO19738 Morus nigra Species Moraceae Eukaryota n.a. twig n.a. PMID[21401118]
NPO19738 Morus nigra Species Moraceae Eukaryota twigs Xinjiang Uygur Autonomous Region, China 2006-MAY PMID[21401118]
NPO19738 Morus nigra Species Moraceae Eukaryota root bark Konya, Turkey 2007-APR PMID[24901948]
NPO19738 Morus nigra Species Moraceae Eukaryota n.a. n.a. Database[FooDB]
NPO19738 Morus nigra Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1970 Cell Line THP-1 Homo sapiens IC50 = 4000 nM PMID[24901948]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC477529 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9573 High Similarity NPC147363
0.9573 High Similarity NPC17105
0.9573 High Similarity NPC474276
0.9573 High Similarity NPC73899
0.9437 High Similarity NPC195136
0.9387 High Similarity NPC82330
0.9383 High Similarity NPC473009
0.9375 High Similarity NPC105584
0.9325 High Similarity NPC473010
0.9321 High Similarity NPC473012
0.9268 High Similarity NPC251336
0.9259 High Similarity NPC301256
0.9259 High Similarity NPC312273
0.9255 High Similarity NPC15815
0.9212 High Similarity NPC292233
0.9198 High Similarity NPC226462
0.9198 High Similarity NPC98023
0.9198 High Similarity NPC121647
0.9193 High Similarity NPC1796
0.9193 High Similarity NPC257166
0.9187 High Similarity NPC79375
0.9187 High Similarity NPC37253
0.9146 High Similarity NPC63438
0.9136 High Similarity NPC51247
0.9136 High Similarity NPC295090
0.9136 High Similarity NPC123544
0.913 High Similarity NPC54830
0.913 High Similarity NPC56049
0.9125 High Similarity NPC121568
0.9102 High Similarity NPC287884
0.9102 High Similarity NPC8704
0.908 High Similarity NPC42965
0.9074 High Similarity NPC475184
0.9074 High Similarity NPC208258
0.9024 High Similarity NPC92589
0.9018 High Similarity NPC51760
0.9018 High Similarity NPC125969
0.9012 High Similarity NPC20530
0.9012 High Similarity NPC32867
0.9012 High Similarity NPC69531
0.9012 High Similarity NPC215917
0.9012 High Similarity NPC10754
0.9006 High Similarity NPC236756
0.9006 High Similarity NPC311579
0.9 High Similarity NPC178484
0.8982 High Similarity NPC286230
0.8982 High Similarity NPC253730
0.897 High Similarity NPC475106
0.897 High Similarity NPC473011
0.8957 High Similarity NPC322459
0.8957 High Similarity NPC323627
0.8957 High Similarity NPC287789
0.8957 High Similarity NPC271741
0.8957 High Similarity NPC324358
0.8957 High Similarity NPC318527
0.8951 High Similarity NPC134171
0.8951 High Similarity NPC300668
0.8951 High Similarity NPC182555
0.8951 High Similarity NPC66441
0.8944 High Similarity NPC477957
0.8944 High Similarity NPC115601
0.8944 High Similarity NPC43345
0.8944 High Similarity NPC473996
0.8944 High Similarity NPC78324
0.8944 High Similarity NPC208011
0.8944 High Similarity NPC39154
0.8935 High Similarity NPC118128
0.8929 High Similarity NPC53252
0.8922 High Similarity NPC476255
0.8916 High Similarity NPC38591
0.8909 High Similarity NPC476929
0.8902 High Similarity NPC90497
0.8896 High Similarity NPC61112
0.8896 High Similarity NPC198489
0.8896 High Similarity NPC309648
0.8889 High Similarity NPC20907
0.8889 High Similarity NPC244250
0.8889 High Similarity NPC100134
0.8889 High Similarity NPC293286
0.8889 High Similarity NPC324447
0.8889 High Similarity NPC209760
0.8882 High Similarity NPC472636
0.8882 High Similarity NPC476551
0.8882 High Similarity NPC472580
0.8882 High Similarity NPC476553
0.8882 High Similarity NPC476552
0.8876 High Similarity NPC279209
0.8876 High Similarity NPC102277
0.8875 High Similarity NPC3642
0.8869 High Similarity NPC476459
0.8862 High Similarity NPC169471
0.8848 High Similarity NPC306978
0.8848 High Similarity NPC172687
0.8841 High Similarity NPC161650
0.8837 High Similarity NPC476210
0.8837 High Similarity NPC476199
0.8834 High Similarity NPC205026
0.8834 High Similarity NPC207809
0.8834 High Similarity NPC304207
0.8834 High Similarity NPC100049
0.8834 High Similarity NPC265624
0.8834 High Similarity NPC121649
0.8834 High Similarity NPC248739
0.8834 High Similarity NPC217706
0.8834 High Similarity NPC259710
0.8834 High Similarity NPC215203
0.8834 High Similarity NPC258474
0.8834 High Similarity NPC52611
0.8834 High Similarity NPC158027
0.8834 High Similarity NPC111341
0.8834 High Similarity NPC201227
0.8834 High Similarity NPC48579
0.8834 High Similarity NPC476169
0.8834 High Similarity NPC304745
0.8834 High Similarity NPC477958
0.8834 High Similarity NPC186227
0.8834 High Similarity NPC159707
0.8834 High Similarity NPC14606
0.8834 High Similarity NPC150908
0.8827 High Similarity NPC171651
0.8827 High Similarity NPC476238
0.8827 High Similarity NPC216035
0.8827 High Similarity NPC174086
0.8827 High Similarity NPC327269
0.8827 High Similarity NPC138288
0.8827 High Similarity NPC31627
0.8827 High Similarity NPC35567
0.8827 High Similarity NPC243171
0.8827 High Similarity NPC210597
0.8827 High Similarity NPC217149
0.8824 High Similarity NPC257667
0.8824 High Similarity NPC186847
0.8824 High Similarity NPC472454
0.8824 High Similarity NPC476159
0.882 High Similarity NPC476509
0.882 High Similarity NPC472421
0.8817 High Similarity NPC63514
0.8817 High Similarity NPC107627
0.8817 High Similarity NPC54903
0.8817 High Similarity NPC286074
0.8812 High Similarity NPC152233
0.8812 High Similarity NPC122894
0.881 High Similarity NPC62444
0.8802 High Similarity NPC472581
0.8802 High Similarity NPC290160
0.8802 High Similarity NPC159508
0.8802 High Similarity NPC469395
0.8795 High Similarity NPC18380
0.8795 High Similarity NPC137232
0.8795 High Similarity NPC97812
0.8793 High Similarity NPC150977
0.8788 High Similarity NPC311574
0.8788 High Similarity NPC264932
0.8786 High Similarity NPC244903
0.8786 High Similarity NPC121888
0.878 High Similarity NPC192587
0.878 High Similarity NPC78492
0.878 High Similarity NPC146636
0.878 High Similarity NPC208152
0.8779 High Similarity NPC101991
0.8779 High Similarity NPC156955
0.8773 High Similarity NPC223701
0.8773 High Similarity NPC303485
0.8773 High Similarity NPC290830
0.8773 High Similarity NPC7989
0.8773 High Similarity NPC268193
0.8773 High Similarity NPC203080
0.8773 High Similarity NPC72425
0.8773 High Similarity NPC472583
0.8773 High Similarity NPC248793
0.8773 High Similarity NPC180301
0.8773 High Similarity NPC71061
0.8773 High Similarity NPC194593
0.8772 High Similarity NPC168789
0.8772 High Similarity NPC475080
0.8772 High Similarity NPC476311
0.8772 High Similarity NPC476152
0.8772 High Similarity NPC469393
0.8765 High Similarity NPC254412
0.8765 High Similarity NPC474744
0.8765 High Similarity NPC471677
0.8765 High Similarity NPC244577
0.8765 High Similarity NPC474772
0.8765 High Similarity NPC472423
0.8765 High Similarity NPC262038
0.8765 High Similarity NPC472422
0.8765 High Similarity NPC262039
0.8765 High Similarity NPC472420
0.8765 High Similarity NPC476196
0.8765 High Similarity NPC278476
0.8765 High Similarity NPC471675
0.8765 High Similarity NPC469344
0.8765 High Similarity NPC263384
0.8765 High Similarity NPC92815
0.8765 High Similarity NPC471229
0.8765 High Similarity NPC476162
0.8765 High Similarity NPC319910
0.8765 High Similarity NPC471676
0.8758 High Similarity NPC473016
0.8758 High Similarity NPC132345

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC477529 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8951 High Similarity NPD8443 Clinical (unspecified phase)
0.8841 High Similarity NPD7075 Discontinued
0.8706 High Similarity NPD7804 Clinical (unspecified phase)
0.8683 High Similarity NPD6959 Discontinued
0.8659 High Similarity NPD7096 Clinical (unspecified phase)
0.8639 High Similarity NPD7852 Clinical (unspecified phase)
0.8589 High Similarity NPD4380 Phase 2
0.8529 High Similarity NPD6168 Clinical (unspecified phase)
0.8529 High Similarity NPD6166 Phase 2
0.8529 High Similarity NPD6167 Clinical (unspecified phase)
0.8509 High Similarity NPD4378 Clinical (unspecified phase)
0.8509 High Similarity NPD7410 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD7768 Phase 2
0.8424 Intermediate Similarity NPD7411 Suspended
0.8373 Intermediate Similarity NPD6801 Discontinued
0.8323 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD7819 Suspended
0.8294 Intermediate Similarity NPD5494 Approved
0.8284 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.825 Intermediate Similarity NPD1549 Phase 2
0.8232 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8225 Intermediate Similarity NPD3882 Suspended
0.8192 Intermediate Similarity NPD7808 Phase 3
0.8187 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD3749 Approved
0.8155 Intermediate Similarity NPD1934 Approved
0.8144 Intermediate Similarity NPD6599 Discontinued
0.8136 Intermediate Similarity NPD7251 Discontinued
0.8136 Intermediate Similarity NPD6559 Discontinued
0.811 Intermediate Similarity NPD6799 Approved
0.8079 Intermediate Similarity NPD6797 Phase 2
0.8057 Intermediate Similarity NPD7473 Discontinued
0.8045 Intermediate Similarity NPD8312 Approved
0.8045 Intermediate Similarity NPD8313 Approved
0.8023 Intermediate Similarity NPD7074 Phase 3
0.8012 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD2796 Approved
0.7966 Intermediate Similarity NPD7054 Approved
0.7966 Intermediate Similarity NPD5844 Phase 1
0.7964 Intermediate Similarity NPD5403 Approved
0.7953 Intermediate Similarity NPD3817 Phase 2
0.795 Intermediate Similarity NPD1510 Phase 2
0.7921 Intermediate Similarity NPD7472 Approved
0.791 Intermediate Similarity NPD3818 Discontinued
0.7886 Intermediate Similarity NPD6232 Discontinued
0.7866 Intermediate Similarity NPD2800 Approved
0.7861 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD5402 Approved
0.7844 Intermediate Similarity NPD5401 Approved
0.7826 Intermediate Similarity NPD1607 Approved
0.7826 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7814 Intermediate Similarity NPD8434 Phase 2
0.7814 Intermediate Similarity NPD8150 Discontinued
0.7812 Intermediate Similarity NPD1240 Approved
0.7798 Intermediate Similarity NPD1512 Approved
0.7791 Intermediate Similarity NPD2801 Approved
0.779 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD7390 Discontinued
0.776 Intermediate Similarity NPD7871 Phase 2
0.776 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.776 Intermediate Similarity NPD7870 Phase 2
0.7758 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7711 Intermediate Similarity NPD3750 Approved
0.7709 Intermediate Similarity NPD3751 Discontinued
0.7708 Intermediate Similarity NPD7435 Discontinued
0.7708 Intermediate Similarity NPD7697 Approved
0.7708 Intermediate Similarity NPD7696 Phase 3
0.7708 Intermediate Similarity NPD7698 Approved
0.7688 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD8455 Phase 2
0.7679 Intermediate Similarity NPD1511 Approved
0.7661 Intermediate Similarity NPD7458 Discontinued
0.7644 Intermediate Similarity NPD6777 Approved
0.7644 Intermediate Similarity NPD6781 Approved
0.7644 Intermediate Similarity NPD6779 Approved
0.7644 Intermediate Similarity NPD6776 Approved
0.7644 Intermediate Similarity NPD6782 Approved
0.7644 Intermediate Similarity NPD6778 Approved
0.7644 Intermediate Similarity NPD6780 Approved
0.764 Intermediate Similarity NPD3926 Phase 2
0.7633 Intermediate Similarity NPD2533 Approved
0.7633 Intermediate Similarity NPD2534 Approved
0.7633 Intermediate Similarity NPD2532 Approved
0.7627 Intermediate Similarity NPD1247 Approved
0.7614 Intermediate Similarity NPD919 Approved
0.7607 Intermediate Similarity NPD6651 Approved
0.7596 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD3787 Discontinued
0.7563 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7563 Intermediate Similarity NPD7874 Approved
0.7562 Intermediate Similarity NPD4908 Phase 1
0.7551 Intermediate Similarity NPD7701 Phase 2
0.7544 Intermediate Similarity NPD920 Approved
0.753 Intermediate Similarity NPD2344 Approved
0.7525 Intermediate Similarity NPD7801 Approved
0.7513 Intermediate Similarity NPD8151 Discontinued
0.75 Intermediate Similarity NPD4628 Phase 3
0.75 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7487 Intermediate Similarity NPD8320 Phase 1
0.7487 Intermediate Similarity NPD8319 Approved
0.747 Intermediate Similarity NPD6100 Approved
0.747 Intermediate Similarity NPD1551 Phase 2
0.747 Intermediate Similarity NPD6099 Approved
0.7457 Intermediate Similarity NPD3226 Approved
0.7448 Intermediate Similarity NPD7699 Phase 2
0.7448 Intermediate Similarity NPD7700 Phase 2
0.7444 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD1243 Approved
0.7427 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD3748 Approved
0.741 Intermediate Similarity NPD2799 Discontinued
0.7403 Intermediate Similarity NPD2403 Approved
0.7391 Intermediate Similarity NPD5953 Discontinued
0.7382 Intermediate Similarity NPD4363 Phase 3
0.7382 Intermediate Similarity NPD4360 Phase 2
0.7382 Intermediate Similarity NPD6534 Approved
0.7382 Intermediate Similarity NPD6535 Approved
0.7381 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7377 Intermediate Similarity NPD7286 Phase 2
0.7365 Intermediate Similarity NPD2935 Discontinued
0.7362 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD2309 Approved
0.735 Intermediate Similarity NPD7783 Phase 2
0.735 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7341 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD6355 Discontinued
0.7323 Intermediate Similarity NPD7584 Approved
0.7322 Intermediate Similarity NPD7228 Approved
0.7308 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD6823 Phase 2
0.7294 Intermediate Similarity NPD7003 Approved
0.7293 Intermediate Similarity NPD7229 Phase 3
0.7288 Intermediate Similarity NPD5761 Phase 2
0.7288 Intermediate Similarity NPD5760 Phase 2
0.7288 Intermediate Similarity NPD1465 Phase 2
0.7282 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD4287 Approved
0.7256 Intermediate Similarity NPD6798 Discontinued
0.7238 Intermediate Similarity NPD7199 Phase 2
0.7232 Intermediate Similarity NPD37 Approved
0.7228 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6234 Discontinued
0.7222 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD2346 Discontinued
0.7207 Intermediate Similarity NPD4967 Phase 2
0.7207 Intermediate Similarity NPD4965 Approved
0.7207 Intermediate Similarity NPD4966 Approved
0.7198 Intermediate Similarity NPD5710 Approved
0.7198 Intermediate Similarity NPD5711 Approved
0.7194 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD4361 Phase 2
0.716 Intermediate Similarity NPD5406 Approved
0.716 Intermediate Similarity NPD5405 Approved
0.716 Intermediate Similarity NPD5408 Approved
0.716 Intermediate Similarity NPD5404 Approved
0.7152 Intermediate Similarity NPD2313 Discontinued
0.7143 Intermediate Similarity NPD8127 Discontinued
0.7143 Intermediate Similarity NPD7097 Phase 1
0.7134 Intermediate Similarity NPD6832 Phase 2
0.7126 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD5124 Phase 1
0.7125 Intermediate Similarity NPD1610 Phase 2
0.7125 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD1471 Phase 3
0.7118 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD6233 Phase 2
0.7101 Intermediate Similarity NPD7033 Discontinued
0.7093 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD6273 Approved
0.7074 Intermediate Similarity NPD7685 Pre-registration
0.7056 Intermediate Similarity NPD8285 Discontinued
0.7052 Intermediate Similarity NPD6190 Approved
0.7048 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD3764 Approved
0.7043 Intermediate Similarity NPD7799 Discontinued
0.7043 Intermediate Similarity NPD7177 Discontinued
0.7039 Intermediate Similarity NPD7577 Discontinued
0.7033 Intermediate Similarity NPD7907 Approved
0.7015 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD2798 Approved
0.6988 Remote Similarity NPD4625 Phase 3
0.6984 Remote Similarity NPD6765 Approved
0.6984 Remote Similarity NPD7240 Approved
0.6984 Remote Similarity NPD6764 Approved
0.6977 Remote Similarity NPD2424 Discontinued
0.6971 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6968 Remote Similarity NPD1729 Discontinued
0.6964 Remote Similarity NPD943 Approved
0.6964 Remote Similarity NPD1613 Approved
0.6964 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6964 Remote Similarity NPD4060 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data